Table 2 Baseline characteristics in the patients with complete clinical and radiographic data divided by: A) radiological progression or not during the first 24 months (increase in total SHS score > 5 points) and B) hand bone loss or not during the first 12 months (DXR-BMD change rate ≥ 2.5 mg/cm 2 /month)
Radiological progression | Hand bone loss | |||||
|---|---|---|---|---|---|---|
YES (N = 43) | NO (N = 101) | p-value | YES (N = 23) | NO (N = 126) | p-value | |
Symptom duration, months | 6.25 (3.27) | 5.98 (3.15) | 0.70 | 5.97 (3.13) | 6.70 (3.66) | 0.30 |
T-SHS = 0,% | 27.9 | 47.5 | 0.04 | 30.5 | 43.7 | 0.26 |
ES =0,% | 46.5 | 63.4 | 0.04 | 47.8 | 59.5 | 0.36 |
DAS 28 | 5.89 (1.01) | 5.60 (1.00) | 0.13 | 5.86 (0.95) | 5.66 (0.98) | 0.37 |
ESR (mm) | 49.8 (30.9) | 31.57 (20.9) | <0.001 | 46.6 (25.9) | 37.1 (26.7) | 0.12 |
CRP (mg/L) | 47.7 (41.7) | 27.2 (36.2) | <0.001 | 56.9 (47.4) | 30.8 (37.6) | 0.004 |
RF pos.% | 38.3 | 28.6 | 0.30 | 35.5 | 30.5 | 0.68 |
ACPA pos.% | 64.0 | 41.4 | 0.60 | 56.5 | 61.4 | 0.65 |